Glycated Hemoglobin Is Associated With the Growth Rate of Abdominal Aortic Aneurysms
- 1 April 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 37 (4) , 730-736
Abstract
Objective—: An inverse association between abdominal aortic aneurysms (AAAs) and diabetes mellitus exists; however, the cause remains unknown. This study aimed to evaluate whether the degree of glycemia is associated with aneurysm growth. Approach and Results—: The study was based on VIVA trial (Viborg Vascular), the randomized clinically controlled screening trial for abdominal aortic aneurysm in men aged 65 to 74 years in the Central Denmark Region. The screening included measurement of the abdominal aorta by ultrasound, analysis of glycated hemoglobin (HbA1c), and follow-up for ≤5 years for aneurysms P P =0.002). Both crude and adjusted analyses identified slower growth for the group with the highest HbA1c tertile compared with the lowest HbA1c tertile. After 3 years, the mean difference was 1.8 mm (confidence interval, 0.98–2.64). Similar significant differences were observed in subgroup analysis of individuals without self-reported diabetes mellitus. Conclusions—: We found an inverse association between the growth rate of abdominal aortic aneurysms and the level of HbA1c, indicating that long-lasting elevated blood sugar impairs aneurysmal progression in individuals with and without known diabetes mellitus.Keywords
This publication has 33 references indexed in Scilit:
- Prognosis of ruptured abdominal aortic aneurysms in Denmark from 1994–2008Clinical Epidemiology, 2012
- The Strange Relationship between Diabetes and Abdominal Aortic AneurysmEuropean Journal of Vascular and Endovascular Surgery, 2012
- Hyperglycemia limits experimental aortic aneurysm progressionJournal of Vascular Surgery, 2010
- Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individualsJournal of Vascular Surgery, 2010
- Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm diseaseSurgery, 2010
- The Viborg vascular (VIVA) screening trial of 65-74 year old men in the central region of Denmark: study protocolTrials, 2010
- Vessel Shrinkage as a Sign of Atherosclerosis Progression in Type 2 DiabetesDiabetes, 2009
- Traditional and Novel Risk Factors for Clinically Diagnosed Abdominal Aortic Aneurysm: The Kaiser Multiphasic Health Checkup Cohort StudyAnnals of Epidemiology, 2007
- Intravascular ultrasound assessment of remodelling and reference segment plaque burden in type-2 diabetic patientsEuropean Heart Journal, 2007
- Endothelial dysfunction in diabetesBritish Journal of Pharmacology, 2000